100–200 mcg — reported, not studied
100–200 mcg once or twice a day, continued for weeks at a time, under the skin. The one study that dosed anyone for 16 weeks watched the growth-hormone response fall by nearly half over that period.
| Water added | Concentration | Draw, low to high |
|---|---|---|
| 1 mL | 5.00 mg/mL | 2.0 to 4.0 units |
| 2 mL | 2.50 mg/mL | 4.0 to 8.0 units |
indirect evidenceDominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol 2026 — tabulates self-reported online dosing patterns beside the clinical doses, stating the reported values must not be read as clinically validated, regulatory-approved or safe · retrieved 2026-08-12
